Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/hyphens-pharma-licenses-wynzora-cream-for-asean-countries-from-mc2-therapeutics-302086586.html
https://www.globenewswire.com//news-release/2024/02/26/2834992/0/en/MC2-Therapeutics-to-Present-at-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2023/12/07/2792387/0/en/MC2-Therapeutics-Announces-Completion-of-Enrollment-in-MC2-25-Ph2-Chronic-Kidney-Disease-associated-Pruritus-Trial.html
https://www.globenewswire.com//news-release/2023/11/23/2785220/0/en/MC2-Therapeutics-Announces-First-Patients-Enrolled-in-Phase-2-Proof-of-Concept-Clinical-Trial-in-Vulvar-Lichen-Sclerosus.html
https://www.globenewswire.com//news-release/2023/10/11/2758334/0/en/MC2-Therapeutics-Announces-Positive-Phase-2a-Results-of-Novel-HSP90-Inhibitor-for-Hidradenitis-Suppurativa-Presented-at-EADV.html
https://endpts.com/mc2-therapeutics-gears-up-for-phase-iib-hidradenitis-suppurativa-trial-following-early-clinical-results/
https://www.globenewswire.com/news-release/2022/10/21/2539263/0/en/EPI-Health-a-Novan-Company-and-MC2-Therapeutics-Announce-Data-from-Survey-Conducted-by-National-Psoriasis-Foundation-Presented-at-42nd-Annual-Fall-Clinical-Dermatology-Conference.html
https://www.clinicaltrialsarena.com/news/mc2-therapeutics-ckd-ap-trial/
https://www.globenewswire.com/news-release/2022/09/15/2516825/0/en/EPI-Health-a-Novan-Company-and-MC2-Therapeutics-Present-WYNZORA-calcipotriene-and-betamethasone-dipropionate-Cream-0-005-0-064-Subgroup-Data-Analysis-at-Skin-of-Color-Update-2022-C.html
https://www.prnewswire.com/news-releases/mc2-therapeutics-announces-initiation-of-a-phase-2-clinical-trial-in-ckd-ap-301623538.html